|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/55 | |
| A61K 31/337 | |||
| A61P 25/04 | |||
| C07K 14/47 | |||
| C12N 15/09 |
| (11) | Patento numeris | 2857037 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13796572.9 |
| Europos patento paraiškos padavimo data | 2013-05-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-04-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-06-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2013/063743 |
| Data | 2013-05-17 |
| (87) | Numeris | WO 2013/179910 |
| Data | 2013-12-05 |
| (30) | Numeris | Data | Šalis |
| 2012125316 | 2012-05-31 | JP |
| (72) |
KAWABATA Atsufumi, JP
SUZUKI Hideaki, JP
|
| (73) |
Kinki University,
4-1, Kowakae 3-chome, Higashiosaka-shi, Osaka 577-8502,
JP
Asahi Kasei Pharma Corporation, 1-1-2 Yurakucho,, Chiyoda-ku Tokyo 100-0006, JP |
| (54) | AGENT FOR PREVENTING AND/OR TREATING PERIPHERAL NEUROPATHIC PAIN CAUSED BY ANTI-CANCER DRUG |
| AGENT FOR PREVENTING AND/OR TREATING PERIPHERAL NEUROPATHIC PAIN CAUSED BY ANTI-CANCER DRUG |